Pharmaceutical

Q&A: Increasing awareness around digital therapeutics key to realising full potential

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest trends and challenges in the digital therapeutics space.

Mar 16, 2024 - 00:00
Q&A: Increasing awareness around digital therapeutics key to realising full potential
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the latest trends and challenges in the digital therapeutics space.
Read the original article

Tags:

Previous Article

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

Next Article

Xcovery edges closer to FDA approval for NSCLC ALK inhibitor

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ESCMID 2024: Using AI in infection prevention and control

ESCMID 2024: Using AI in infection prevention and control

Apr 29, 2024

STAT+: Pharmalittle: Amazon Pharmacy offers insulin discounts; DOJ blasts industry attempt to delay Medicare drug-price talks

STAT+: Pharmalittle: Amazon Pharmacy offers insulin dis...

Aug 15, 2023

STAT+: Pharmalittle: We’re reading about worries over a Novo deal, a PBM bill, and more

STAT+: Pharmalittle: We’re reading about worries over a...

Feb 7, 2024